Literature DB >> 3532015

Intracranial hemorrhage during extracorporeal membrane oxygenation in neonates.

R E Cilley, J B Zwischenberger, A F Andrews, R A Bowerman, D W Roloff, R H Bartlett.   

Abstract

Intracranial hemorrhage is a complication of extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure. A retrospective review of 35 neonates treated with extracorporeal membrane oxygenation was performed; ten had intracranial hemorrhage. Infants with intracranial hemorrhage had lower birth weights and were gestationally younger than infants with intracranial hemorrhage. Eight of eight neonates of less than 35 weeks' gestational age sustained intracranial hemorrhage. Six died immediately after extracorporeal membrane oxygenation was stopped. Two lived less than 1 year. Two of 27 neonates older than 34 weeks' gestational age sustained intracranial hemorrhage. One child is normal, the other died at 18 months of age. Based on the results of this study, the risk of intracranial hemorrhage appears low in neonates of greater than 34 weeks' gestational age who undergo extracorporeal membrane oxygenation treatment for severe respiratory failure. The use of extracorporeal membrane oxygenation, as it is presently performed, is contraindicated in neonates of less than 35 weeks' gestational age because of the risk of intracranial hemorrhage.

Entities:  

Mesh:

Year:  1986        PMID: 3532015

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Histological changes in the hearts of non-survivors of the UK collaborative trial of neonatal ECMO (extra corporeal membrane oxygen).

Authors:  M J Evans; J W Keeling
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

2.  Neonatal respiratory extracorporeal membrane oxygenation and primary diagnosis: trends between two decades.

Authors:  Jotishna Sharma; Ashley Sherman; Anisha Rimal; Barb Haney; Julie Weiner; Eugenia Pallotto
Journal:  J Perinatol       Date:  2019-11-07       Impact factor: 2.521

Review 3.  An overview of extracorporeal membrane oxygenation therapy.

Authors:  M B Madonna; R M Arensman
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

4.  Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation.

Authors:  Melania M Bembea; William Savage; John J Strouse; Jamie McElrath Schwartz; Ernest Graham; Carol B Thompson; Allen Everett
Journal:  Pediatr Crit Care Med       Date:  2011-09       Impact factor: 3.624

Review 5.  A paradigm shift in the treatment of extreme prematurity: the artificial placenta.

Authors:  Ryan P Davis; Benjamin Bryner; George B Mychaliska
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

6.  Adrenal hemorrhage in infants undergoing ECMO: prevalence and clinical significance.

Authors:  C M Sivit; B L Short; M E Revenis; L C Rebolo; C Brown-Jones; D B Garin
Journal:  Pediatr Radiol       Date:  1993

7.  Extracorporeal life support for neonatal respiratory failure. A 20-year experience.

Authors:  C J Shanley; R B Hirschl; R E Schumacher; M C Overbeck; T N Delosh; R A Chapman; A G Coran; R H Bartlett
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

8.  Pathological complications of non-survivors of newborn extracorporeal membrane oxygenation.

Authors:  M J Evans; P A McKeever; G A Pearson; D Field; R K Firmin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

9.  Ultrasonographic findings (CNS, thorax, abdomen) in infants undergoing extracorporeal oxygenation therapy.

Authors:  T L Slovis; L L Sell; M P Bedard; M D Klein
Journal:  Pediatr Radiol       Date:  1988

10.  Use of venovenous ECMO for neonatal and pediatric ECMO: a decade of experience at a tertiary children's hospital.

Authors:  Jennifer L Carpenter; Yangyang R Yu; Darrell L Cass; Oluyinka O Olutoye; James A Thomas; Cole Burgman; Caraciolo J Fernandes; Timothy C Lee
Journal:  Pediatr Surg Int       Date:  2018-01-18       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.